$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Bandage for transdermally administering scopolamine to prevent nausea 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61F-007/02
  • A61L-015/06
출원번호 US-0721602 (1976-09-07)
발명자 / 주소
  • Urquhart John (Palo Alto CA) Chandrasekaran Santosh Kumar (Palo Alto CA) Shaw Jane Elizabeth (Atherton CA)
출원인 / 주소
  • Alza Corporation (Palo Alto CA 02)
인용정보 피인용 횟수 : 187  인용 특허 : 0

초록

Method and therapeutic system in the form of a bandage that administer scopolamine base transdermally in an initial pulse of 10 to 200 m2 of skin that quickly brings the concentration of scopolamine in the plasma to a level at which emesis and nausea are inhibited without intolerable side effects, f

대표청구항

A therapeutic system in the form of a bandage for administering scopolamine base through unbroken skin to inhibit emesis and nausea for a prolonged time period comprising a sandwich-type laminate of: (a) a backing lamina that is substantially impermeable to scopolamine base, one face of which forms

이 특허를 인용한 특허 (187)

  1. Knight, James; Cartt, Steve; Young, David; Becker, Patrice, ACTH for treatment of acute respiratory distress syndrome.
  2. Cartt, Steve; Gong, Rujun, ACTH prophylactic treatment of renal disorders.
  3. Cartt, Steve; Gong, Rujun, ACTH prophylactic treatment of renal disorders.
  4. Zaffaroni Alejandro (Atherton CA) Wong Patrick S. L. (Hayward CA), Active agent dispenser.
  5. von Bittera Miklos (Leverkusen DEX) Meyer Rolf-Volker (Krefeld DEX), Active compound release systems.
  6. von Bittera Miklos (Leverkusen DEX) Meyer Rolf-Volker (Krefeld DEX) Dhein Rolf (Krefeld DEX), Active compound release systems.
  7. Akemi, Hitoshi; Ninomiya, Kazuhisa; Kuroda, Hidetoshi; Matsuoka, Kensuke; Saeki, Yuji; Nishimura, Masato, Adhesive material and adhesive preparation.
  8. Ito, Takeshi; Tateishi, Tetsuro; Higo, Naruhito, Adhesive patch for fentanyl administration.
  9. Saeki, Yuji; Nishimura, Masato; Matsuoka, Kensuke; Muraoka, Takateru; Hosaka, Yoshifumi; Hori, Mitsuhiko; Ninomiya, Kazuhisa; Akemi, Hitoshi; Kuroda, Hidetoshi, Adhesive preparation containing fentanyl.
  10. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  11. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  12. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  13. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  14. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  15. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  16. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  17. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  18. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  19. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  20. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  21. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  22. Nelson Eric L. (Newport Beach CA) Vaidyanathan Rajaram (Laguna Niguel CA), Bandage for transdermal delivery of systemically-active drug.
  23. Kanios,David; Mantelle,Juan A.; Houze,David, Barrier film lined backing layer composition and method for topical administration of active agents.
  24. Harrison Boyd L. (Cincinnati OH) Ku George (Burlington MA) Meikrantz Scott B. (Carson City NV) Dalton Christopher R. (Mundelein IL) Stemerick David M. (Fairfield OH), Benzenesulfonylimine derivatives as inhibitors of IL-1 action.
  25. Chiu, Gordon, Biotherapeutics for the treatment of infectious diseases.
  26. Chiu, Gordon, Biotherapeutics for the treatment of infectious diseases.
  27. Ross, Russell Frederick, Composite microneedle array including nanostructures thereon.
  28. Ross, Russell Frederick, Composite microneedle array including nanostructures thereon.
  29. Kanios, David P.; Mantelle, Juan A., Compositions and methods for delivery of amino-functional drugs.
  30. Bozik, Michael E.; Petzinger, Jr., Thomas; Mather, James L.; Archibald, Donald, Compositions and methods for treating amyotrophic lateral sclerosis in responders.
  31. Bozik, Michael E.; Petzinger, Jr., Thomas; Mather, James L.; Archibald, Donald, Compositions and methods for treating amyotrophic lateral sclerosis in responders.
  32. Bozik, Michael E.; Dworetzky, Steven, Compositions and methods for treating chronic urticaria.
  33. Bozik, Michael E; Dworetzky, Steven, Compositions and methods for treating chronic urticaria.
  34. Bozik, Michael E.; Hebrank, Gregory; Farwell, Wildon; Petzinger, Jr., Thomas; Dworetzky, Steven, Compositions and methods for treating conditions related to increased eosinophils.
  35. Bozik, Michael E.; Dworetzky, Steven, Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders.
  36. Bozik, Michael E.; Dworetzky, Steven, Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders.
  37. Bozik, Michael E.; Gribkoff, Valentin; Petzinger, Jr., Thomas, Compositions and methods of using (R)-pramipexole.
  38. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Compositions and methods of using (R)-pramipexole.
  39. Minaskanian Gevork (Irvine CA) Peck James V. (Costa Mesa CA), Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes.
  40. Tseng, Scheffer; He, Hua, Compositions containing HC-HA complex and methods of use thereof.
  41. Tseng, Scheffer; He, Hua; Tighe, Sean; Zhang, Suzhen; Zhu, Ying-Tieng, Compositions containing HC-HA/PTX3 complexes and methods of use thereof.
  42. Tseng, Scheffer; He, Hua; Tighe, Sean; Zhang, Suzhen; Zhu, Ying-Tieng, Compositions containing HC-HA/PTX3 complexes and methods of use thereof.
  43. Drust Eugene G. (Norwich NY) Kasting Gerald B. (Wyoming OH) Smith Ronald L. (West Chester OH) Szkutak Joan B. (West Chester OH), Compositions for the transdermal delivery of pharmaceutical actives.
  44. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Compositions of R(+) and S(−) pramipexole and methods of using the same.
  45. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Compositions of R(+) and S(−) pramipexole and methods of using the same.
  46. Tseng, Scheffer; Chua, Lorraine, Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof.
  47. Cao, Jianguo; Wang, Zhijun; Grey, Jonathan; Rogers, Evan; Whitten, Jeffrey P., Compounds that modulate intracellular calcium.
  48. Rogers, Evan; Cao, Jianguo; Wang, Zhijun; Grey, Jonathan; Whitten, Jeffrey P., Compounds that modulate intracellular calcium.
  49. Yamabe,Haruko; Okuyama,Masahiro; Nakao,Akira; Ooizumi,Mitsuru; Saito,Ken ichi, Cyclic amide derivatives.
  50. DeVillez Richard L. ; Crane Laura J., Device for delivery of dermatological ingredients.
  51. Ross, Russell Frederick, Device for delivery of rheumatoid arthritis medication.
  52. Ross, Russell Frederick, Device for delivery of rheumatoid arthritis medication.
  53. Leeson Lewis J. (Roseland NJ), Devices and methods for treating memory impairment.
  54. Prisco, Michael R.; Yardimci, Atif M.; Acikgoz, Serhan; Laird, James C.; Maliekkal, Shincy J.; Rohde, Justin B., Dialysis systems and methods having vibration-aided air removal.
  55. Childers, Robert W.; Busby, Donald D.; Hogard, Michael E.; Prisco, Michael R.; Yardimci, Atif M.; Laird, James C., Dialysis systems having air separation chambers with internal structures to enhance air removal.
  56. Yardimci, Atif M.; Laird, James C., Dialysis systems having air separation chambers with internal structures to enhance air removal.
  57. Prisco, Michael R.; Yardimci, Atif M.; Acikgoz, Serhan; Laird, James C.; Maliekkal, Shincy J.; Rohde, Justin B., Dialysis systems having air traps with internal structures to enhance air removal.
  58. Panoz Donald E. (Athlone IEX), Drug delivery device.
  59. Enscore David J. ; Campbell Patricia S. ; Nedberge Diane ; Frame Richard D., Drug delivery devices and process of manufacture.
  60. Enscore David J. ; Campbell Patricia S. ; Nedberge Diane ; Frame Richard D., Drug delivery devices and process of manufacture.
  61. Kim Benjamin K. (Toms River NJ), Estradiol transdermal delivery system.
  62. Prisco, Michael R.; Yardimci, Atif M.; Acikgoz, Serhan; Laird, James C.; Maliekkal, Shincy J.; Rohde, Justin B., Fluid delivery systems and methods having floating baffle aided air removal.
  63. Williams, Simon F., Flushable disposable polymeric products.
  64. Kumar, Ravi Seshagirirao, Formulations and methods for treatment of metabolic syndrome.
  65. Gale, Robert M.; Nelson, Melinda K.; Cormier, Michel J. N.; Gupta, Suneel K.; Campbell, Patricia S., Formulations for the administration of fluoxetine.
  66. Gale,Robert M.; Nelson,Melinda K.; Cormier,Michel J. N.; Gupta,Suneel K.; Campbell,Patricia S., Formulations for the administration of fluoxetine.
  67. van Osdol, William W.; Crisologo, Nieves M.; Yum, Su Il, Formulations for the transdermal administration of fenoldopam.
  68. van Osdol, William W.; Crisologo, Nieves M.; Yum, Su Il, Formulations for the transdermal administration of fenoldopam.
  69. Yum Su I ; Nelson Melinda K. ; Campbell Patricia S., Formulations for transdermal delivery of pergolide.
  70. Yum, Su Il; Nelson, Melinda K.; Campbell, Patricia S., Formulations for transdermal delivery of pergolide.
  71. Ku George (Burlington MA) Harrison Boyd L. (Cincinnati OH) Stemerick David M. (Fairfield OH), Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action.
  72. Arnold, Lee Daniel; Murphy, Eric A., Heterocyclic compounds useful for kinase inhibition.
  73. Arnold, Lee Daniel; Murphy, Eric A., Heterocyclic compounds useful for kinase inhibition.
  74. Landrau Felix A. ; Nedberge Diane E. ; Hearney Linda Mary, Incorporating poly-N-vinyl amide in a transdermal system.
  75. Beaton, Graham; Tucci, Fabio; Ravula, Satheesh B.; Wang, Hua-Yu, Inhibition of OLIG2 activity.
  76. Ross, Russell Frederick, Injection molded microneedle array and method for forming the microneedle array.
  77. Dudar, Thomas; Krogh, Ross; Martucci, James; Sternberg, Shmuel, Intravenous pumping air management systems and methods.
  78. Dudar, Thomas; Krogh, Ross; Martucci, James; Sternberg, Shmuel, Intravenous pumping air management systems and methods.
  79. Dudar, Thomas; Krogh, Ross; Martucci, James; Sternberg, Shmuel, Intravenous pumping air management systems and methods.
  80. Theeuwes Felix (Los Altos CA) Yum Su I. (Los Altos CA), Intravenous system for delivering a beneficial agent.
  81. Theeuwes Felix (Los Altos CA) Yum Su I. (Los Altos CA), Intravenous system for delivering a beneficial agent.
  82. Sirkar, Kamalesh K.; Fan, Qiuxi, Iontophoretic transdermal drug delivery system based on conductive polyaniline membrane.
  83. von Bittera Miklos (Leverkusen DEX) Dhein Rolf (Krefeld DEX) Meyer Rolf-Volker (Krefeld DEX) Rupp Roland (Leichlingen DEX), Isobutylene polymer active compound release systems.
  84. Mohr Judy M. (Menlo Park CA) Baker Richard W. (Palo Alto CA) Nakaji Lisa A. (San Jose CA), Liquid reservoir transdermal patch for the administration of ketorolac.
  85. Gerhart, William; Keller, Manfred; Tutuncu, Ahmet; Soni, Pravin, Mast cell stabilizers treatment for systemic disorders.
  86. Gerhart, William; Keller, Manfred; Tutuncu, Ahmet; Soni, Pravin, Mast cell stabilizers treatment for systemic disorders.
  87. Gerhart, William; Keller, Manfred; Tutuncu, Ahmet; Soni, Pravin, Mast cell stabilizers treatment for systemic disorders.
  88. Gerhart, William; Keller, Manfred; Tutuncu, Ahmet; Soni, Pravin, Mast cell stabilizers treatment for systemic disorders.
  89. Gale Robert M. (Los Altos CA), Medical bandage for administering beneficial drug.
  90. Gale Robert M. (Mountain View CA), Medical bandage for administering vasodilator drug.
  91. Gale Robert M. (Los Altos CA) Berggren Randall (Livermore CA), Medical device for pulsatile transdermal delivery of biologically active agents.
  92. Williams, Simon F.; Martin, David P.; Skraly, Frank A., Medical devices and applications of polyhydroxyalkanoate polymers.
  93. Rizk, Said; Martin, David P.; Ho, Kicherl; Williams, Simon F., Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers.
  94. Ross, Russell Frederick, Medical devices for delivery of siRNA.
  95. Ross, Russell Frederick, Medical devices for delivery of siRNA.
  96. Shaw Jane (Atherton CA) Gale Robert M. (Mountain View CA), Method comprising transdermal and buccal treatment of angina.
  97. Gale Robert M. (Mountain View CA), Method for increasing oxygen supply by administering vasodilator.
  98. Ross, Russell Frederick, Method for increasing the permeability of an epithelial barrier.
  99. Gale Robert M. (Mountain View CA), Method for lessening the incidence of anginal attacks.
  100. Dohner John W. ; Bura Scott A. ; Ford Richard E., Method for preventing crystal formation in a dispersion of a liquid in a matrix.
  101. Dohner, John W.; Bura, Scott A.; Ford, Richard E., Method for preventing crystal formation in a dispersion of a liquid in a matrix.
  102. Dohner,John W.; Bura,Scott A., Method for preventing crystal formation in a dispersion of a liquid in a matrix.
  103. Braun Richard L. (Colts Neck NJ), Method for the prevention or removal of crystalline scopolamine in a non-aqueous matrix of a transdermal system.
  104. Shaw Jane (Atherton CA) Gale Robert M. (Mountain View CA), Method for treating ischemic conditions.
  105. Gale Robert M. (Mountain View CA), Method for treating nocturnal angina.
  106. Osborne James L. (2365 Thompson Ct. Mountain View CA 94043) Nelson Melinda K. (1127 Hollenbeck Sunnyvale CA 94087) Enscore David J. (18291 Montpere Way Saratoga CA 95070) Yum Su I. (1021 Runnymead Ct, Method of administering nicotine transdermally.
  107. Martin, David P.; Rizk, Said; Ahuja, Ajay; Williams, Simon F., Method of making a medical textile from polyhydroxyalkanoate fibers.
  108. Rizk, Said, Method of making a polyhydroxyalkanoate filament.
  109. Peck James V. (Costa Mesa CA) Minaskanian Gevork (Irvine CA), Methods for administration using 1-substituted azacycloalkanes.
  110. Gerhart, William; Soni, Pravin; Tutuncu, Ahmet, Methods for the treatment of mast cell related disorders with mast cell stabilizers.
  111. Gerhart, William; Keller, Manfred; Tutuncu, Ahmet; Soni, Pravin, Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders.
  112. Robert Martin Gale, Methods for transdermal drug administration.
  113. Cummings Steven ; Ellman Herman ; Ettinger Bruce, Methods for treating postmenopausal women using ultra-low doses of estrogen.
  114. Cummings, Steven R.; Ettinger, Bruce; Ellman, Herman, Methods for treating postmenopausal women using ultra-low doses of estrogen.
  115. Tseng, Scheffer; Tan, Ek Kia; He, Hua, Methods of modulating bone remodeling.
  116. Tseng, Scheffer; Tan, Ek Kia; He, Hua, Methods of modulating bone remodeling.
  117. Ganatra, Amit; Felix, Fabio; Shah, Bhavin; Bernasconi, Matthew; Rizk, Said; Martin, David P.; Williams, Simon F., Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof.
  118. Ganatra, Amit; Felix, Fabio; Shah, Bhavin; Bernasconi, Matthew; Rizk, Said; Martin, David P.; Williams, Simon F., Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof.
  119. Tseng, Scheffer; Tan, Ek Kia; Chua, Lorraine, Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof.
  120. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same.
  121. Lee Eun Soo ; Watanabe Tyler ; Gale Robert M. ; Burkoth Terry L., Monoglyceride/lactate ester permeation enhancer for oxybutnin.
  122. Lee Eun Soo ; Watanabe Tyler ; Gale Robert M. ; Burkoth Terry L., Monoglyceride/lactate ester permeation enhancer for oxybutynin.
  123. Koenig, David W.; Joseph, Wael R., Multilayer absorbent article.
  124. Koenig, David W.; Joseph, Wael R., Multilayer absorbent article.
  125. Ross, Russell Frederick, Nanopatterned medical device with enhanced cellular interaction.
  126. Minaskanian Gevork (Irvine CA) Peck James V. (Costa Mesa CA), Penetration enhancers for transdermal delivery of systemic agent.
  127. Asmussen, Bodo; Hille, Thomas; Hoffmann, Hans-Rainer; Opitz, Klaus, Pharmaceutical composition containing deoxypeganine for the treatment of nicotine dependence.
  128. Asmussen, Bodo; Hille, Thomas; Hoffmann, Hans-Rainer; Opitz, Klaus, Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism.
  129. Nagy Jzsef (Budapest HUX) Salamon Ferenc (Budapest HUX) Wagner Odn (Budapest HUX), Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same.
  130. Bodor Nicholas (Gainesville FL), Physiological means of enhancing transdermal delivery of drugs.
  131. Bodor Nicholas (Gainesville FL), Physiological means of enhancing transdermal delivery of drugs.
  132. Martin, David P.; Rizk, Said; Ahuja, Ajay; Williams, Simon F., Polyhydroxyalkanoate medical textiles and fibers.
  133. Martin, David P.; Rizk, Said; Ahuja, Ajay; Williams, Simon F., Polyhydroxyalkanoate medical textiles and fibers.
  134. Martin, David P.; Rizk, Said; Ahuja, Ajay; Williams, Simon F., Polyhydroxyalkanoate medical textiles and fibers.
  135. Martin, David P.; Rizk, Said; Ahuja, Ajay; Williams, Simon F., Polyhydroxyalkanoate medical textiles and fibers.
  136. Wang Karly S. (Newark CA) Osborne James L. (Mountain View CA) Hunt James A. (Fremont CA) Nelson Melinda K. (Sunnyvale CA), Polyisobutylene adhesives for transdermal devices.
  137. Young James (Corvallis OR) Leatherman Dennis D. (Upper St. Clair PA), Printed microporous material.
  138. Martin, David P.; Rizk, Said; Ahuja, Ajay; Williams, Simon F., Process of making polyhydroxyalkanoate medical textiles.
  139. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  140. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  141. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  142. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  143. Chen, Wei; Loury, David J., Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors.
  144. Tuttle, Susan Bane; Dilek, Ozlem; Mukherjee, Kamalika, Rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjunction therewith.
  145. Lothar W. Kleiner ; Robert M. Gale ; Randall G. Berggren ; Gilbert T. Tong ; Guohua Chen ; Keith E. Dionne ; Paul R. Houston, Rate controlling membranes for controlled drug delivery devices.
  146. Cormier Michel J. N. ; Daddona Peter E. ; Johnson Juanita A., Reduction of skin reactions caused by transdermal drug delivery.
  147. Loubert, Gary Lee; Menjoulet, Tiffany Anne; Mitchell, Timothy Paul; Thomas, Xavier Jean-Paul, Silicone acrylate hybrid composition and method of making same.
  148. Loubert, Gary; Mitchell, Timothy P.; Thomas, Xavier, Silicone acrylate hybride composition and method of making same.
  149. Evans, Chana Wilson; Huber, Robert O.; Kanios, David P.; Loubert, Gary Lee; Menjoulet, Tiffany Anne; Mitchell, Timothy Paul; Nartker, Linda Sue; Thomas, Xavier Jean-Paul, Single phase silicone acrylate formulation.
  150. Schwarz Richard A. (Akron OH) Leigh Thomas H. (Uniontown OH) Leatherman Dennis D. (Pittsburgh PA), Stretched microporous material.
  151. Osborne James L. (Mountain View CA) Nelson Melinda (Sunnyvale CA) Enscore David J. (Saratoga CA) Yum Su I. (Los Altos CA) Gale Robert M. (Los Altos CA), Subsaturated nicotine transdermal therapeutic system.
  152. Osborne James L. ; Nelson Melinda ; Enscore David J. ; Yum Su Il ; Gale Robert M., Subsaturated nicotine transdermal therapeutic system.
  153. Enscore David J. (Sunnyvale CA) Campbell Patricia S. (Palo Alto CA) Osborne James L. (Mountain View CA) Smart Melinda K. (Sunnyvale CA) Yum Su I. (Los Altos CA), Subsaturated transdermal therapeutic system having improved release characteristics.
  154. Chen, Weirong; Humora, Michael; Kwok, Daw-Iong Albert; Kiesman, William F.; Irdam, Erwin Ayandra, Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds.
  155. Chen, Weirong; Humora, Michael; Kwok, Daw-long Albert; Kiesman, William F.; Irdam, Erwin Ayandra, Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds.
  156. Raje, Prasad; Gadikota, Rajendrakumar Reddy; Chen, Jian-Xie; Lapina, Olga V.; McCall, John M., Synthesis of chirally purified substituted benzothiazole diamines.
  157. Raje, Prasad; Gadikota, Rajendrakumar Reddy; Chen, Jian-Xie; Lapina, Olga V.; McCall, John M., Synthesis of chirally purified substituted benzothiazole diamines.
  158. Murphy, Eric A.; Cheresh, David A.; Arnold, Lee Daniel, Therapeutic methods and compositions involving allosteric kinase inhibition.
  159. Chandrasekaran Santosh K. (Palo Alto CA) Darda Siegfried (Ingelheim am Rhein CA DEX) Michaels Alan S. (Atherton CA) Cleary Gary W. (Palo Alto CA), Therapeutic system for administering clonidine transdermally.
  160. Nakamura Kenji (3-7 Higashiyodogawa-ku ; Osaka JPX), Toilet article.
  161. Chew,Nora Yat Knork; Reed,Barry Leonard; Morgan,Timothy Matthias; Finnin,Barrie Charles, Topical delivery of antifungal agents.
  162. Enscore David J. (Sunnyvale CA) Lee Eun S. (Redwood City CA) Yum Su I. (Los Altos CA), Transdermal delivery device having a rate controlling adhesive.
  163. Yum, Su Il; Theeuwes, Felix, Transdermal delivery system for sufentanil.
  164. Yum, Su Il; Theeuwes, Felix, Transdermal delivery system for sufentanil.
  165. Stefano, Francisco Jose Evaristo; Scasso, Alejandro Fabio, Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised.
  166. Yum, Su Il; Theeuwes, Felix, Transdermal delivery systems.
  167. Sanders Harold F. (Palo Alto CA) Cheng Yu-Ling (Cupertino CA) Enscore David J. (Saratoga CA) Libicki Shari B. (Palo Alto CA), Transdermal drug composition with dual permeation enhancers.
  168. Lee,Eun Soo; Yum,Su Il, Transdermal drug delivery device.
  169. Watanabe, Tyler; Gale, Robert M., Transdermal drug delivery device package with improved drug stability.
  170. Woodard John T. (Midland MI) Metevia Virgil L. (Saginaw MI), Transdermal drug delivery devices with amine-resistant silicone adhesives.
  171. Woodard John T. (Midland MI) Metevia Virgil L. (Saginaw MI), Transdermal drug delivery devices with amine-resistant silicone adhesives.
  172. Tang, Jiansheng, Transdermal drug delivery systems comprising a coated release liner.
  173. Chien Yie W. (North Brunswick NJ) Chien Te-Yen (Piscataway NJ) Huang Yih-Chain (Piscataway NJ), Transdermal estrogen/progestin dosage unit, system and process.
  174. Zeltman, Jon, Transdermal patch and method for delivery of vitamin B12.
  175. Ross, Russell F., Transdermal patch containing microneedles.
  176. Hille Thomas,DEX ; Muller Walter,DEX ; Asmussen Bodo,DEX, Transdermal therapeutic system and a process for the combined transdermal application of physostigmine and scopolamine.
  177. Deshmukh, Abhijit Mukund; Dixit, Akhilesh; Kumar, Prasanna; Bindra, Vikram, Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders.
  178. Chien Yie W. (North Brunswick NJ) Tojo Kakuji (Highland Park NJ), Transdermal varapamil delivery device.
  179. Koch, Andreas, Transdermal, therapeutic system with activatable oversaturation and controlled permeation promotion.
  180. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  181. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  182. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  183. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  184. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  185. Ebert, Charles D.; Sanders, Steven W., Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy.
  186. Bond, Richard A.; Glass, Mitchell, Use of beta-adrenergic inverse agonists for smoking cessation.
  187. Opitz, Klaus; Moormann, Joachim; Hille, Thomas; Becher, Frank, Use of galanthamine for the treatment of pathological manifestations of the central nervous system based on intoxications with psychotropic substances.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로